U.S. Inks $5.3 Billion Deal For Pfizer’s Antiviral Covid Pill — Growing Its Stockpile Of New Coronavirus Treatments

The deal will secure the U.S. 10 million courses of Pfizer’s experimental Covid-19 pill, providing it is approved by regulators.

Read the full post at Forbes - Healthcare
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive